These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 917016)
1. Involvement of the kinin system in the insulin-induced inhibition of carrageenin oedema in rats. Ottlecz A; Gecse A; Koltai M; West GB Monogr Allergy; 1977; 12():131-7. PubMed ID: 917016 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of carrageenin foot oedema by 1,10 -phenanthroline and evidence for the bradykinin as endogenous mediator. Capasso F; Balestrieri B; Di Rosa M; Persico P; Sorrentino L Agents Actions; 1975 Oct; 5(4):359-63. PubMed ID: 1211310 [TBL] [Abstract][Full Text] [Related]
3. [Kinins and oedema induced by different carrageenans (author's transl)]. Damas J; Remacle-Volon G J Pharmacol; 1982; 13(2):225-39. PubMed ID: 7098485 [TBL] [Abstract][Full Text] [Related]
4. Kinins and peritoneal exudates induced by carrageenin and zymosan in rats. Damas J; Bourdon V; Remacle-Volon G; Adam A Br J Pharmacol; 1990 Oct; 101(2):418-22. PubMed ID: 2257442 [TBL] [Abstract][Full Text] [Related]
5. Studies on mechanisms of action of emorfazone. Effects on the release of bradykinin-like substance in thermic edema of rat paws. Sato M; Yamaguchi A Arzneimittelforschung; 1982; 32(4):379-82. PubMed ID: 7201806 [TBL] [Abstract][Full Text] [Related]
6. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG). Campos MM; Henriques MG; Calixto JB Br J Pharmacol; 1997 Feb; 120(3):502-8. PubMed ID: 9031756 [TBL] [Abstract][Full Text] [Related]
7. [Kinins-formation, hypotensive and oedematogen activities of four carrageenans (author's transl)]. Damas J Pathol Biol (Paris); 1980 May; 28(5):287-92. PubMed ID: 6992064 [TBL] [Abstract][Full Text] [Related]
8. Effect of Ginkgo biloba extract on carrageenan-induced acute local inflammation in gamma irradiated rats. Hedayat I; Salam OM; Baiuomy AR Pharmazie; 2005 Aug; 60(8):614-9. PubMed ID: 16124406 [TBL] [Abstract][Full Text] [Related]
9. Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction. Griesbacher T; Legat FJ Br J Pharmacol; 1997 Mar; 120(5):933-9. PubMed ID: 9138701 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy. Vianna RM; Calixto JB Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617 [TBL] [Abstract][Full Text] [Related]
11. Involvement of guanylate cyclase and potassium channels on the delayed phase of mouse carrageenan-induced paw oedema. Fernandes D; Assreuy J Eur J Pharmacol; 2004 Oct; 501(1-3):209-14. PubMed ID: 15464080 [TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat. Pichat P; Angel I; Arbilla S Arzneimittelforschung; 1998 Feb; 48(2):173-8. PubMed ID: 9541729 [TBL] [Abstract][Full Text] [Related]
13. [Kinin system of the blood and myocardium in monitored limitation of the coronary blood flow]. Gunina LM Vopr Med Khim; 1981; 27(5):630-3. PubMed ID: 6171933 [TBL] [Abstract][Full Text] [Related]
14. Mediators of the inflammation induced in the rat paw by carrageenin. Crunkhorn P; Meacock SC Br J Pharmacol; 1971 Jul; 42(3):392-402. PubMed ID: 4104654 [TBL] [Abstract][Full Text] [Related]
15. Some pharmacodynamic properties of carrageenin in the rat. Di Rosa M; Sorrentino L Br J Pharmacol; 1970 Jan; 38(1):214-20. PubMed ID: 4391733 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of carrageenin-induced rat paw oedema by substances causing a reduction of kininogen and prekallikrein in plasma. Briseid K; Arntzen FC; Dyrud OK Acta Pharmacol Toxicol (Copenh); 1971; 29(23):265-74. PubMed ID: 5108610 [No Abstract] [Full Text] [Related]
17. Polymyxin B-induced oedema in hind paw of the rat as an assay for antiinflammatory drugs. Bertelli A; Soldani G Arzneimittelforschung; 1979; 29(5):777-8. PubMed ID: 227421 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of kininogen and degradation of bradykinin by PC12 cells. Dendorfer A; Wellhöner P; Braun A; Roscher AA; Dominiak P Br J Pharmacol; 1997 Dec; 122(8):1585-92. PubMed ID: 9422802 [TBL] [Abstract][Full Text] [Related]
19. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy. Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811 [TBL] [Abstract][Full Text] [Related]
20. The role of the kinin system in various inflammatory models in the rat. Damas J; Remacle-Volon G; Adam A Int J Tissue React; 1984; 6(5):391-9. PubMed ID: 6519919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]